Document is current
Any future updates will be listed below
-
Authors
Zhang, Wei
Ling, Qing
Wang, Bin
Wang, Kai
Pang, Jianbo
Lu, Jing
Bi, Yan
Zhu, Dalong https://orcid.org/0000-0001-6760-5379
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02763423 at ClinicalTrials.govDocuments that mention this clinical trial
Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes
https://doi.org/10.1186/s13287-022-02974-1
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China (2017YFC1309605)
Nanjing Health Youth Talent (QRX17123)
Nanjing Science and Technology Development Project (YKK21080)
Jiangsu Provincial Key Medical Discipline (ZDXKB2016012)
- License Information
-
More Information
Article History
Received: 12 January 2022
Accepted: 13 June 2022
First Online: 8 August 2022
Declarations
:
: The clinical study was approved by the Ethics Committee of Affiliated Drum Tower Hospital, Medical School of Nanjing University (Approval Number: 2008017, 2009004). Written informed consent was obtained from all participants and/or guardians as well as from donors of MSCs. All animal procedures were approved by the Animal Ethics Committee of Affiliated Drum Tower Hospital, Medical School of Nanjing University (Approval Number: 2019AE01100).
: Consent for publication was obtained from every participant.
: The authors declare that they have no competing interests.
